0001853373-25-000001.txt : 20250221 0001853373-25-000001.hdr.sgml : 20250221 20250221170055 ACCESSION NUMBER: 0001853373-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250221 DATE AS OF CHANGE: 20250221 EFFECTIVENESS DATE: 20250221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kestrel Therapeutics Inc. CENTRAL INDEX KEY: 0001853373 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-538994 FILM NUMBER: 25652904 BUSINESS ADDRESS: STREET 1: 102 SEARS ROAD CITY: WAYLAND STATE: MA ZIP: 01778 BUSINESS PHONE: 617-460-3772 MAIL ADDRESS: STREET 1: 102 SEARS ROAD CITY: WAYLAND STATE: MA ZIP: 01778 D 1 primary_doc.xml X0708 D LIVE 0001853373 Kestrel Therapeutics Inc. Attn Pagliuca Harvard Life Lab 127 Western Ave. Boston MA MASSACHUSETTS 02134 617-460-3772 DELAWARE None None Corporation true 2020 Frank G. Haluska Attn: Pagliuca Harvard Life Lab 127 Western Ave. Boston MA MASSACHUSETTS 02134 Executive Officer Director Denis Patrick Attn: Pagliuca Harvard Life Lab 127 Western Ave. Boston MA MASSACHUSETTS 02134 Director Omar Khalil Attn: Pagliuca Harvard Life Lab 127 Western Ave. Boston MA MASSACHUSETTS 02134 Director Andrew Phillips Attn: Pagliuca Harvard Life Lab 127 Western Ave. Boston MA MASSACHUSETTS 02134 Director Nicholas Saccomano Attn: Pagliuca Harvard Life Lab 127 Western Ave. Boston MA MASSACHUSETTS 02134 Director Barbara Sosnowski Attn: Pagliuca Harvard Life Lab 127 Western Ave. Boston MA MASSACHUSETTS 02134 Director Biotechnology Decline to Disclose 06b false 2025-02-07 false true true true false 0 16000000 8000000 8000000 false 7 0 0 0 false Kestrel Therapeutics Inc. Frank G. Haluska Frank G. Haluska President and Chief Executive Officer 2025-02-21